HSDD is also known as the female sexual interest-arousal disorder (FSAID) or female sexual dysfunction (FSD). A large 2008 study estimated that an average of 4 million U.S. Women between the age of 30 and 70 were affected. There are other research studies that disagree with this number, but the truth remains that the problem is real. As a matter of fact, a study published in the American Journal of Obstetrics and Gynaecology showed that at least 40 percent of women will suffer from HSDD in their lifetime. Apart from killing sex drive, when you are suffering from HSDD, it affects other areas of your life. You might develop quality-of-life issues, relationship issues, and self-esteem issues. The FDA-approved solution? Flibanserin, also known as the female Viagra or the brand name Addyi. Flibanserin has been approved by the FDA for treating HSDD in premenopausal women. Some even called it the "little pink pill" just to make it similar to Viagra's nickname - "the little blue pill." However, there is no basis for comparison between the two, each of them functions differently. Viagra works in men by pumping blood to the penis for them to achieve an erection after stimulation, whereas, Flibanserin works by boosting your desire for sex. The way the female Viagra works is what you will learn in this short guide. Apart from learning how it works, you will also learn Uses, Dosage, Risks, Contraindications and whether or not it is harmful for treating hypoactive sexual desire disorder (HSDD).